A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease

Completed · Phase 3

Conditions studied: Crohn's Disease

In brief

The purpose of this trial is to evaluate natalizumab in individuals with moderately to severely active Crohn's Disease.

Key facts

Study ID
NCT00078611
Run by
Biogen
People needed
462
Starts
2004-03-01
Expected to finish
2005-03-01
Last updated by the study team
2016-06-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.